NCT01765231 2017-01-10Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With LymphomaPeking UniversityPhase 4 Unknown190 enrolled
NCT01768195 2017-01-10Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based ImmunochemotherapyPeking UniversityPhase 4 Unknown80 enrolled